Chan Anson Huen-Yan, Ho Man-Fung, Lee Janet Fung-Yee, Wong Jeffrey Ka-Tak, Ng Simon Siu-Man
Department of Surgery, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong Special Administrative Region.
Department of Surgery, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong Special Administrative Region.
Int J Surg Case Rep. 2021 Feb;79:123-130. doi: 10.1016/j.ijscr.2020.12.082. Epub 2021 Jan 9.
To present two cases of acute non-cirrhotic and non-malignant mesenteric vein thrombosis (MVT) treated with early transcatheter thrombectomy and thrombolysis with tissue plasminogen activator (tPA) and to review the literature on transcatheter thrombectomy and thrombolytic therapy of such condition.
Two cases of acute MVT treated with transhepatic transcatheter thrombectomy and thrombolysis in addition to systemic anticoagulation upon diagnosis are presented. In addition, a Pubmed literature search was undertaken using keywords acute mesenteric vein thrombosis, thrombolysis and thrombectomy. The inclusion criteria were studies examining the impacts of transcatheter thrombolysis and thrombectomy in the management of acute MVT.
Early transcatheter thrombectomy and thrombolysis achieves technical success in both patients and result in nearly complete recanalization of the venous system, with no recurrent thrombosis to date in follow up. Both patients do not require extensive bowel resection despite extensive thrombus on presentation. However, both patients develop intra-abdominal bleeding requiring blood transfusion and embolization of the transcatheter tract.
Catheter-directed first approach provides a minimal invasive approach for management of non-malignant and non-cirrhotic acute mesenteric thrombosis. It offers the benefits of rapid venous recanalization and avoid massing bowel resection despite extensive thrombosis. Subsequent progression into chronic MVT was also reduced. However, the procedure could lead to bleeding from puncture site and hence embolization of the catheter tract is advised during catheter removal.
介绍两例采用早期经导管血栓切除术及组织型纤溶酶原激活剂(tPA)溶栓治疗的急性非肝硬化非恶性肠系膜静脉血栓形成(MVT)病例,并回顾此类疾病经导管血栓切除术及溶栓治疗的相关文献。
介绍两例诊断后采用经肝经导管血栓切除术及溶栓治疗并辅以全身抗凝治疗的急性MVT病例。此外,使用关键词“急性肠系膜静脉血栓形成”“溶栓”和“血栓切除术”在PubMed上进行文献检索。纳入标准为研究经导管溶栓和血栓切除术在急性MVT治疗中的影响的研究。
早期经导管血栓切除术及溶栓治疗在两名患者中均取得技术成功,静脉系统几乎完全再通,随访至今无复发性血栓形成。尽管两名患者就诊时血栓广泛,但均无需进行广泛肠切除。然而,两名患者均发生腹腔内出血,需要输血及对经导管通道进行栓塞。
导管直接介入的首要方法为非恶性非肝硬化急性肠系膜血栓形成的治疗提供了一种微创方法。它具有快速静脉再通的优点,尽管血栓广泛,但可避免进行广泛肠切除。后续发展为慢性MVT的情况也有所减少。然而,该操作可能导致穿刺部位出血,因此建议在拔除导管时对导管通道进行栓塞。